Latest
Diagnostic Delay in Diffuse Large B-Cell Lymphoma Linked to Poorer Outcomes for Patients With Worse Disease
Symptom Burden in Polycythemia Vera Unrelated to Controlled Blood Counts
Depressive Symptoms May Be Associated With Survival in Patients With Hematologic Malignancies
Prevalence of Gastrointestinal Bleeding in Patients With von Willebrand Disease
Slow-Release Iron Treatment Appears Safe and Efficacious in Patients With Iron Deficiency Anemia
Extended Oral Anticoagulation Therapy for First Unprovoked Deep Vein Thrombosis
Inhibitor Development Is Rare After 75 Days of Exposure to Factor VIII in Severe Hemophilia A
Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
Hospital Admission Rates in Children With Sickle Cell Disease Seeking Pain Management
HIV-Induced Expression of PD-L1 on Regulatory B Cells May Promote AIDS-Related NHL
After Long-Term Ibrutinib Therapy for CLL, BTK Mutations May Signal Progression
Anemia Drug Works Regardless of Prior ESA Treatment
Featured Content
Current and Prospective Treatment Strategies for Follicular Lymphoma
In addition to current obinutuzumab- and rituximab-based treatment regimens, several novel agents have received approval for follicular lymphoma treatment.
New Treatment Options Needed for Immune Thrombocytopenia
Current treatment strategies for immune thrombocytopenic purpura are centered on immunomodulation and decreasing platelet destruction
Does Preemptive Stem Cell Transplant Have Value for Patients at Genetic Risk for Leukemia?
Many clinical and ethical factors influence whether preemptive transplant would be beneficial for patients genetically predisposed to acute myeloid leukemia.
Pregnant Patients With Lymphoma Can Be Safely and Effectively Treated
Though lymphoproliferative diseases during pregnancy can lead to complications, a host of treatment options exists.
Clinical Management of Inhibitors in Children With Hemophilia
Treatment strategies for children with hemophilia who have inhibitors should involve eradicating the inhibitor and managing bleeding.
